Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis

This publication has 39 references indexed in Scilit:

• The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis
  Current Medical Research and Opinion, 2004
• Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation
  Allergy, 2004
• Montelukast improves symptoms of seasonal allergic rhinitis over a 4‐week treatment period
  Allergy, 2003
• Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis
  Annals of Allergy, Asthma & Immunology, 2003
• Montelukast for treating seasonal allergic rhinitis: a randomized, double‐blind, placebo‐controlled trial performed in the spring
  Clinical and Experimental Allergy, 2002
• Clinical evidence for antileukotriene therapy in the management of allergic rhinitis
  Annals of Allergy, Asthma & Immunology, 2002
• Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial
  Journal of Allergy and Clinical Immunology, 2000
• Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract.
  American Journal of Respiratory and Critical Care Medicine, 1996
• Nitric oxide and asthmatic inflammation
  Immunology Today, 1995
• Prevalence and impact of multiple childhood chronic illnesses
  The Journal of Pediatrics, 1994